TSXV:NEWU - Post Discussion
Post by
pkdale on Aug 12, 2020 4:32pm
NEWU - baby Livongo LVGO in the making?
Glad to be one of the first posts on this name. In time others will start to get up to speed on this story and recognize its potential.
SO 90/FD 116
Cash ~$1m
- digital chronic disease prevention platform that operates at the other end of the spectrum of LVGO who was just purchased by TDOC for $18.5B
- focuses on habit change by leveraging precision health tools including: genetic testing and behavioural evaluations, to develop and implement personalized programs
- 50% of US population has 2 or more pre-chronic risk factors
- Aetna study results show an ROI of 2x for employers in 1yr that grows over time
- 100% digital (no clinics)
- 100% US (top clients JPM, CVS, Accenture, trial with Haven: JV of AMZN/Berkshire/JPMorgan
- 1 of 16 online providers that is fully approved by the CDC as an Alternate Diabetes Prevention Program, out of >1500 total programs
- estimate are for >50% growth rate over the next 5 years
- 5x2020 rev est vs peers at 20x and LVGO takeover at 55x
Q2 2020 highlights v Q2 2019:
Revenue + 67%, to $2.69 million
GP + 96%, to $1.41 million
GM 52% v 45%
engagement rev 90% v 65% (strongest in company history)
YTD Rev $6.55m & GP $3.06m exceed FY2019 rev & GP of $6.11 m & $1.97m, respectively
Be the first to comment on this post